The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment

Fn14, the cell surface receptor for TWEAK, is over-expressed in various human solid tumor types and can be a negative prognostic indicator. We detected Fn14 expression in ~60% of the melanoma cell lines we tested, including both B-Raf WT and B-Raf(V600E) lines. Tumor tissue microarray analysis indic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhou, Hong, Ekmekcioglu, Suhendan, Marks, John W., Mohamedali, Khalid A., Asrani, Kaushal, Phillips, Keeley K., Brown, Sharron A.N., Cheng, Emily, Weiss, Michele B., Hittelman, Walter N., Tran, Nhan L., Yagita, Hideo, Winkles, Jeffrey A., Rosenblum, Michael G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3600159/
https://ncbi.nlm.nih.gov/pubmed/23190886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2012.402
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados